Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125830711 | 12583071 | 1 | I | 20160104 | 20160714 | 20160722 | 20160722 | EXP | HR-HALMED-2016-01764 | HR-PFIZER INC-2016347295 | PFIZER | 15.00 | YR | Y | 60.00000 | KG | 20160722 | MD | HR | HR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125830711 | 12583071 | 1 | PS | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 19787 | TABLET | ||||||||||
125830711 | 12583071 | 2 | SS | RIVOTRIL | CLONAZEPAM | 1 | Oral | 0 | TABLET | ||||||||||
125830711 | 12583071 | 3 | SS | ZALDIAR | ACETAMINOPHENTRAMADOL HYDROCHLORIDE | 1 | Oral | 0 | FILM-COATED TABLET | ||||||||||
125830711 | 12583071 | 4 | SS | ANDOL | ASPIRIN | 1 | Oral | 0 | TABLET |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125830711 | 12583071 | OT |
125830711 | 12583071 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125830711 | 12583071 | Intentional overdose | |
125830711 | 12583071 | Suicide attempt |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125830711 | 12583071 | 1 | 20160104 | 0 | ||
125830711 | 12583071 | 2 | 20160104 | 0 | ||
125830711 | 12583071 | 3 | 20160104 | 0 | ||
125830711 | 12583071 | 4 | 20160104 | 0 |